2019 Scripps MD Anderson's Oncology Update
Scripps' 2019 ASCO Update on FOLFOXIRI plus Bevacizumab in Unresectable mCRC - Is the Upfront Exposure Beneficial?
By
2019 Scripps MD Anderson's Oncology Update
FEATURING
Darren Sigal
By
2019 Scripps MD Anderson's Oncology Update
FEATURING
Darren Sigal
Login to view comments.
Click here to Login
